JW Asset Management

JW Asset Management is a New York-based investment firm focusing on healthcare investments, employing event-driven trading, volatility strategies, and a bottom-up approach to investing in smaller companies. It operates hedge funds and private equity funds and acts as a registered investment adviser under the SEC, overseeing day-to-day investment decisions. The firm seeks to back innovative management teams with capital and strategic resources to accelerate growth and create long-term value. It has participated as a lead investor in notable acquisitions, including Arbor Pharmaceuticals in 2010 and TerrAscend Corp.

Jason Klarreich

Executive Vice President and CFO

22 past transactions

Tyson 2.0

Series A in 2022
Tyson 2.0 is a cannabis company founded by renowned boxer and entrepreneur Mike Tyson, focused on producing high-quality cannabis products. The company offers a diverse range of offerings, including full-spectrum cannabis flower, concentrates, and consumables, which are designed to ensure both purity and precision. Tyson 2.0 aims to provide consumers with an exceptional selection that balances premium quality and affordability, making its products widely accessible at retailers across the nation.

Allumia

Series A in 2022
Founded in 2013, Allumia specializes in lighting upgrades for commercial facilities. It offers design, funding, installation, and maintenance services, serving markets such as office spaces, retail stores, and industrial plants. The company uses a software and IoT platform to optimize energy efficiency, enabling clients to reduce costs and increase savings.

Pistil Data

Seed Round in 2021
Pistil Data is a market intelligence company specializing in the Consumer Packaged Goods (CPG) sector. It provides comprehensive insights on CPG brands and retailers, enabling businesses to grow through data-driven decisions.

Semasio

Series C in 2021
Founded in 2010, Semasio specializes in targeting solutions for programmatic advertising. It uses Natural Language Processing to analyze website content, generating user profiles that enable clients to create and address specific audiences. Headquartered in Hamburg with offices in New York, Denmark, and Portugal, Semasio serves global agency networks, advertisers, and media agencies.

Cityrow Go

Series A in 2021
CityRow Holdings, Inc. specializes in health and fitness services, offering a unique blend of workouts that include yoga, strength training, and cardio, primarily utilizing water-based rowing machines. Founded in 2014 and headquartered in New York City, the company operates three locations in Michigan and New York. CityRow also provides a digital platform, Cityrow Go, which is a rowing-based fitness app designed for smartphones and tablets. This app features a variety of rowing classes aimed at delivering effective and motivating workouts for users at home. The studio's approach focuses on enhancing aerobic capacity and overall body efficiency through high-intensity interval training that emphasizes low-impact exercises, helping individuals achieve their fitness goals in a scientifically guided manner.

Semasio

Series B in 2021
Founded in 2010, Semasio specializes in targeting solutions for programmatic advertising. It uses Natural Language Processing to analyze website content, generating user profiles that enable clients to create and address specific audiences. Headquartered in Hamburg with offices in New York, Denmark, and Portugal, Semasio serves global agency networks, advertisers, and media agencies.

Gage Cannabis

Venture Round in 2020
Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.

Semasio

Series A in 2020
Founded in 2010, Semasio specializes in targeting solutions for programmatic advertising. It uses Natural Language Processing to analyze website content, generating user profiles that enable clients to create and address specific audiences. Headquartered in Hamburg with offices in New York, Denmark, and Portugal, Semasio serves global agency networks, advertisers, and media agencies.

High 12

Series A in 2019
High 12 is a consumer packaged goods company based in Toronto, Canada, specializing in the development and operation of premier global cannabis brands. Founded in 2018, the company emphasizes a consumer-focused approach, utilizing data-driven analysis to create and launch recognizable cannabis products. High 12 aims to build strong brands that foster community and connection among users, while also forming strategic supply-chain partnerships to enhance its market presence. Through its commitment to brand development, High 12 seeks to establish a significant footprint in the evolving cannabis industry.

Canndescent

Series C in 2019
Canndescent LLC is a cannabis company based in Santa Barbara, California, specializing in the cultivation of premium cannabis flowers for medical purposes. The company employs a proprietary cultivation technology that enhances aromas and flavors, ensuring a consistent product for its customers. Canndescent distinguishes itself by abandoning traditional strain names, allowing for a more straightforward understanding of its offerings. Committed to compliance with state and local regulations, the company manages the entire process from cultivation to packaging and distribution, providing a quality-driven service that emphasizes deep cultivation expertise.

Semasio

Seed Round in 2019
Founded in 2010, Semasio specializes in targeting solutions for programmatic advertising. It uses Natural Language Processing to analyze website content, generating user profiles that enable clients to create and address specific audiences. Headquartered in Hamburg with offices in New York, Denmark, and Portugal, Semasio serves global agency networks, advertisers, and media agencies.

Henry's Original

Series B in 2019
Henry's Original is a producer of handcrafted cannabis products sourced from family-run farms in Mendocino County. Established in mid-2017, the company focuses on delivering health and wellness-oriented cannabis offerings, including flower, pre-rolls, singles, and flower vape cartridges in seasonal varieties and CBD-heavy options. All products are cultivated in Mendocino County, ensuring they meet and exceed California State standards for organic quality. Henry's Original has garnered attention from various media outlets, reflecting its commitment to providing consumers with access to organically grown cannabis directly from the farm.

GrowGeneration

Post in 2019
GrowGeneration operates specialty retail stores focused on hydroponic and organic gardening. It markets and distributes a range of products including nutrients, growing media, advanced lighting systems, ventilation equipment, and accessories for hydroponic gardening.

Vitruvias Therapeutics

Series A in 2018
Vitruvias Therapeutics is a start-up generic pharmaceutical company based in Montgomery, Alabama, founded in 2013. The company specializes in the development of niche topical generic products that are available only by prescription. It focuses on creating complex active pharmaceutical ingredients (APIs) and finished dosage forms that are challenging to manufacture. By leveraging strategic partnerships, Vitruvias aims to address manufacturing complexities and raw material sourcing issues, thereby enhancing the availability of essential generic medications. The company's name is inspired by Leonardo da Vinci's "Vitruvian Man," symbolizing its commitment to achieving the ideal balance and proportionality in pharmaceutical development.

TerrAscend

Post in 2017
TerrAscend is a vertically-integrated Canadian company specializing in cannabis cultivation, processing, and distribution. It offers medical consultations, patient support programs, and hemp-derived wellness products. The company operates retail dispensaries in Canada and the United States.

Vensun Pharmaceuticals

Series C in 2016
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Established in 2011, Vensun focuses on co-developing these products through strategic partnerships both domestically and internationally. The company has filed numerous Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. Vensun is committed to enhancing its development portfolio by pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions.

Establishment Labs

Debt Financing in 2016
Establishment Labs designs, develops, manufactures, and markets silicone-filled breast and body shaping implants worldwide. It offers a range of implant options and provides Q Inside Safety Technology for non-invasive data access. The company also operates a consultation center and offers MotivaImagine application and external sizing system. Its products are sold through exclusive distributors and direct sales force in over 80 countries.

Establishment Labs

Venture Round in 2015
Establishment Labs designs, develops, manufactures, and markets silicone-filled breast and body shaping implants worldwide. It offers a range of implant options and provides Q Inside Safety Technology for non-invasive data access. The company also operates a consultation center and offers MotivaImagine application and external sizing system. Its products are sold through exclusive distributors and direct sales force in over 80 countries.

Aralez Pharmaceuticals

Post in 2015
Aralez Pharmaceuticals is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of products primarily in cardiovascular care, pain management, and other specialized areas. The company offers a range of key products such as Fiorinal, Proferrin, Fibricor, Uracyst, Neovisc, and Cambia. Aralez operates primarily in the United States and Canada, with the majority of its revenue generated from the U.S. market. By serving customers worldwide, Aralez Pharmaceuticals aims to address significant medical needs through its targeted therapeutic offerings.

Vensun Pharmaceuticals

Series B in 2013
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Established in 2011, Vensun focuses on co-developing these products through strategic partnerships both domestically and internationally. The company has filed numerous Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. Vensun is committed to enhancing its development portfolio by pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions.

Vensun Pharmaceuticals

Series A in 2012
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Established in 2011, Vensun focuses on co-developing these products through strategic partnerships both domestically and internationally. The company has filed numerous Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. Vensun is committed to enhancing its development portfolio by pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions.

Arbor Pharmaceuticals

Series B in 2010
Arbor Pharmaceuticals is a specialty pharmaceutical company based in Raleigh, North Carolina, founded in 2006. It primarily focuses on pediatric medicine, licensing, developing, and commercializing late-stage products designed for common pediatric conditions. The company offers a range of products, including ZINOTIC and ZINOTIC ES for treating Acute Otitis Externa, NEOTIC for pain and inflammation associated with Acute Otitis Media, and XYLAREX for dietary management of Recurrent Acute Otitis Media. Additionally, Arbor Pharmaceuticals provides the Pediaderm HC Complete Kit, specifically formulated to treat and protect the skin of children with atopic dermatitis, commonly known as eczema. The company markets its products through specialized sales forces across the United States, while also engaging in research and development in therapeutic areas like cardiology, neurology, and endocrinology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.